AbbVie to Showcase Breadth of Oncology Portfolio and Pipeline at the 2021 ASCO and EHA Annual Congresses

Published by W Butcher on

NORTH CHICAGO, Ill., May 19, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) will present results from 43 abstracts across 12 types of cancer during the upcoming virtual American Society of Clinical Oncology (ASCO) Annual Meeting (June 4-8) and the virtual European Hematology Association (EHA) congress (June 9-17). “We are advancing discovery and innovation to improve on the standards of care for blood cancer treatment,” said Mohamed Zaki, M.D., Ph.D., vice president and global head of oncology development, AbbVie. “We look forward to showcasing research from our expanding oncology portfolio at the ASCO 2021 annual meeting and EHA 2021 congress.”

Read More…

Categories: Uncategorized

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published.